S

Svas Biosana SpA
MIL:SVS

Watchlist Manager
Svas Biosana SpA
MIL:SVS
Watchlist
Price: 9.1 EUR -0.66% Market Closed
Market Cap: €48.5m

Multiples-Based Value

The Multiples-Based Value for Svas Biosana SpA (SVS) under the Base Case is 17.56 EUR. Compared with the current market price of 9.1 EUR, the stock appears Undervalued by 48%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SVS Multiples-Based Value
17.56 EUR
Undervaluation 48%
Multiples-Based Value
Price €9.1
S
Worst Case
Base Case
Best Case

Multiples Across Competitors

SVS Competitors Multiples
Svas Biosana SpA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IT
Svas Biosana SpA
MIL:SVS
48.2m EUR 0.4 7.1 3.5 5.2
JP
Hoya Corp
TSE:7741
9.4T JPY 10.3 37.6 27.2 32.6
US
Medline Inc
NASDAQ:MDLN
58.8B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
28.4B CHF 3.4 36.3 14 27.2
DK
Coloplast A/S
CSE:COLO B
88.8B DKK 3.3 22.8 12.2 14.6
US
Align Technology Inc
NASDAQ:ALGN
12.8B USD 3.2 31.1 13.5 18.5
CA
Bausch + Lomb Corp
NYSE:BLCO
5.8B USD 1.1 -16 17.2 55.6
UK
ConvaTec Group PLC
LSE:CTEC
4.1B GBP 2.2 31.1 11 17.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
37.9B CNY 8.3 23 20.6 20.6
CN
Intco Medical Technology Co Ltd
SZSE:300677
37.3B CNY 3.8 21.9 32.5 32.5
KR
HLB Inc
KOSDAQ:028300
8.1T KRW 95.7 -36.5 -81.6 -77.4
P/E Multiple
Earnings Growth PEG
IT
S
Svas Biosana SpA
MIL:SVS
Average P/E: 26.4
7.1
15%
0.5
JP
Hoya Corp
TSE:7741
37.6
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
CH
Alcon AG
SIX:ALC
36.3
32%
1.1
DK
Coloplast A/S
CSE:COLO B
22.8
21%
1.1
US
Align Technology Inc
NASDAQ:ALGN
31.1
34%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -16 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
31.1
41%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23
9%
2.6
CN
Intco Medical Technology Co Ltd
SZSE:300677
21.9
12%
1.8
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -36.5 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IT
S
Svas Biosana SpA
MIL:SVS
Average EV/EBITDA: 16.9
3.5
10%
0.4
JP
Hoya Corp
TSE:7741
27.2
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
9%
N/A
CH
Alcon AG
SIX:ALC
14
9%
1.6
DK
Coloplast A/S
CSE:COLO B
12.2
6%
2
US
Align Technology Inc
NASDAQ:ALGN
13.5
14%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
17.2
29%
0.6
UK
ConvaTec Group PLC
LSE:CTEC
11
11%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
20.6
13%
1.6
CN
Intco Medical Technology Co Ltd
SZSE:300677
32.5
51%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -81.6 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IT
S
Svas Biosana SpA
MIL:SVS
Average EV/EBIT: 24.9
5.2
11%
0.5
JP
Hoya Corp
TSE:7741
32.6
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
18%
N/A
CH
Alcon AG
SIX:ALC
27.2
26%
1
DK
Coloplast A/S
CSE:COLO B
14.6
7%
2.1
US
Align Technology Inc
NASDAQ:ALGN
18.5
21%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
55.6
72%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
17.2
21%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
20.6
10%
2.1
CN
Intco Medical Technology Co Ltd
SZSE:300677
32.5
24%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -77.4 N/A N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett